Twist Bioscience Corporation (TWST) Balance Sheet

The sequential decline in total assets, coupled with a shrinking equity base (from $560.1M to $445.7M over the same period), suggests that the company is funding its expansion through debt and cash reserves rather than generating internal capital. The persistent negative retained earnings, which have grown from -$1.1B to -$1.4B, reflect cumulative losses that are eroding shareholder value. This trajectory implies that while top-line growth is robust, the balance sheet is not yet self-sustaining, and the company remains dependent on external financing.

The modest increase in leverage, while still low in absolute terms, is notable given the concurrent decline in cash reserves from $243.3M to $117.4M. The spike in debt to $183.9M in 2026Q1, followed by a reduction, suggests possible short-term borrowing to manage liquidity, which may indicate cash flow volatility. The low D/E ratio provides a cushion, but the trend of rising debt alongside falling cash suggests that the company may need to access capital markets if losses persist, potentially leading to dilution.

The rise in net PP&E reflects the ongoing expansion of the 'Factory of the Future' in Oregon, which is critical for scaling production but also increases fixed costs and depreciation. Goodwill has remained constant, suggesting no recent acquisitions, but the $82.2M balance represents a potential impairment risk if growth expectations falter. The asset mix is becoming more capital-intensive, which may pressure returns on assets in the near term but could enable higher margins at scale.

The decline in equity is primarily attributable to net losses, which have outpaced any equity raises or other comprehensive income. The negative retained earnings indicate that the company has not yet achieved profitability, and the equity cushion is shrinking relative to assets. This trend suggests that without a path to positive earnings, the company may need to raise additional capital, which could dilute existing shareholders. The stable goodwill and lack of significant share repurchases indicate that management is focused on growth rather than returning capital.

The substantial reduction in cash and current ratio suggests that the company is consuming its liquidity to fund operations and capital expenditures. Despite the current ratio remaining above 2, the trend is concerning, as the cash runway appears to be shortening. Given the negative operating cash flow and ongoing capex, investors should monitor whether the company can secure additional financing or achieve cash flow breakeven before liquidity becomes constrained.